WO2025134072 - METHODS FOR PREVENTING, TREATING, OR AMELIORATING ULCERATIVE COLITIS IN CERTAIN PATIENT POPULATIONS WITH AMISELIMOD

National phase entry is expected:
Publication Number WO/2025/134072
Publication Date 26.06.2025
International Application No. PCT/IB2024/063070
International Filing Date 20.12.2024
Title **
[English] METHODS FOR PREVENTING, TREATING, OR AMELIORATING ULCERATIVE COLITIS IN CERTAIN PATIENT POPULATIONS WITH AMISELIMOD
[French] MÉTHODES DE PRÉVENTION, DE TRAITEMENT OU D'AMÉLIORATION DE LA RECTOCOLITE HÉMORRAGIQUE CHEZ CERTAINES POPULATIONS DE PATIENTS ATTEINTS D'AMISÉLIMOD
Applicants **
BAUSCH HEALTH IRELAND LIMITED
Inventors
PILLAI, Radhakrishnan
ISRAEL, Robert J.
LEE, Jimin
Priority Data
63/613,604   21.12.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2605
EPO Filing, Examination, Granting13730
Japan Filing, Examination, Granting2450
South Korea Filing, Examination, Granting2508
USA Filing, Examination, Granting5340
MasterCard Visa
Total: 26,633
Abstract[English] Described herein are methods for treating ulcerative colitis (UC) using amiselimod. The method of treatment includes dosing amiselimod at a larger initial dose as compared to the eventual maintenance dose.[French] L'invention concerne des méthodes de traitement de la rectocolite hémorragique (UC) à l'aide d'amisélimod. La méthode de traitement comprend le dosage de l'amisélimod à une dose initiale plus grande par comparaison avec la dose de maintenance éventuelle.

Rejoining the server...